Pediatric Rheumatology

Article	Citations
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches	81
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey	69
Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology	37
Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)	36
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country	33
Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children	32
Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus	30
Intravenous administration of anakinra in children with macrophage activation syndrome	27
Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype	26
Distinguishing active pediatric COVID-19 pneumonia from MIS-C	26
Growth and puberty in children with juvenile idiopathic arthritis	25
Neurological involvement in Kawasaki disease: a retrospective study	24
Telemedicine in pediatric rheumatology: this is the time for the community to embrace a new way of clinical practice	24
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?	21
Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases	21
NLRP12-associated systemic autoinflammatory diseases in children	21
Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)	19
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology	18
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab	17
Proceedings of the 26th European Paediatric Rheumatology Congress: part 2	16
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)	16
Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency	16
Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic	15
Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study	15
Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?	15

A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	15
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER	14
Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature	14
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	14
Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission	14
Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect	14
Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases	14
Pediatric rheumatology in Africa: thriving amidst challenges	13
Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019	13
Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis	13
Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort	13
Similarities and differences between MIS-C and KD: a systematic review and meta-analysis	13
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East	13
Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib	13
Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus	12
Evaluation of pediatric rheumatology telehealth satisfaction during the COVID-19 pandemic	12
The paediatric global musculoskeletal task force - ‘towards better MSK health for all’	12
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	12
Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania	12
Artificial intelligence for interpretation of segments of whole body MRI in CNO: pilot study comparing radiologists versus machine learning algorithm	12
Psychiatric disorders in incident patients with juvenile idiopathic arthritis - a case-control cohort study	12
Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline	11
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review	11
Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation	11
Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials	11
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases	11
Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease	11
Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention	11
Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus	11
Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series	10
Disordered eating among adolescents with chronic pain: the experience of a pediatric rheumatology subspecialty pain clinic	10
Vitamin C deficiency mimicking inflammatory bone disease of the hand	10
Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares	10
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review	10
Chronic nonbacterial osteomyelitis in children: a multicentre Belgian cohort of 30 children	10
Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs)	10
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients	10
Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis	10
Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper forms	10
Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective coho	10
Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study	10
Adenosine deaminase 2 activity negatively correlates with age during childhood	9
Assessing the reporting quality of physical activity programs in randomized controlled trials for the management of juvenile idiopathic arthritis using three standardized assessment tools	9
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	9
High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO)	9
A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan	9
Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA	9
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial	9
Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature	9
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists	9

Glitches in the utilization of telehealth in pediatric rheumatology patients during the COVID-19 pandemic	9
Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus	8
Epidemiology of pediatric uveitis and associated systemic diseases	8
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach	8
Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis	8
Assessment of traditional and non-traditional risk factors for premature atherosclerosis in children with juvenile dermatomyositis and pediatric controls	8
Prosthetic temporomandibular joint reconstruction in a cohort of adolescent females with juvenile idiopathic arthritis	8
Juvenile Spondyloarthritis: focus on uveitis	8
A preliminary study of the child abuse and central sensitization in adolescent patients with chronic non-organic chest pain and an overlooked condition: juvenile fibromyalgia syndrome	8
How children with juvenile idiopathic arthritis view participation and communication in healthcare encounters: a qualitative study	8
Lost bones: differential diagnosis of acro-osteolysis seen by the pediatric rheumatologist	8
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	8
Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report	8
Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children	8
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms	8
Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi–Goutie’res syndrome	8
Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis	8
In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study	8
A novel mutation in early‐onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes	7
Clinical characteristics and genetic analysis of A20 haploinsufficiency	7
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents	7
Reproductive health needs of adolescent and young adult women with pediatric rheumatic diseases	7
Exploring the intersection of adverse childhood experiences, pediatric chronic pain, and rheumatic disease	7
Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study	7
Factors impacting referral of JIA patients to a tertiary level pediatric rheumatology center in North India: a retrospective cohort study	7
TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases	7
Neonatal Kawasaki disease with multiple arterial aneurysms: a case report	7
Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis	7
Leukocytoclastic vasculitis in patients with IL12B or IL12RB1 deficiency: case report and review of the literature	7
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study	7
A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases	7
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	7
Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort	7
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis	7
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review	7
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study	7
Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)	7
Magnetic resonance imaging findings in children with Parry-Romberg syndrome and en coup de sabre	7
Home-based exercise program for adolescents with juvenile dermatomyositis quarantined during COVID-19 pandemic: a mixed methods study	7
Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis	7
Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial	7
I don’t want to think about it: a qualitative study of children (6–18 years) with rheumatic diseases and parents’ experiences with regular needle injections at home	7
Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report	6
Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis	6
C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro	6
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE	6
Anasarca as the presenting symptom of juvenile dermatomyositis: a case series	6
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series	6
Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China	6
Use of PROMIS® to screen for depression in children with arthritis	6
The spectrum of pediatric amplified musculoskeletal pain syndrome	6
Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases	6
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study	6
Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study	6
Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren’s syndrome and mixed connective tissue disease	6
Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series	6
Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement	6
Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience	6
The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis	6
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies	6
Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study	6
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	6
Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic	6
Outcomes of transitional care programs on adolescent chronic inflammatory systemic diseases: systematic review and meta-analyses	6
Age, gender, height and weight in relation to joint cartilage thickness among school-aged children from ultrasonographic measurement	6
IgA vasculitis nephritis clinical course and kidney biopsy – national study in children	6
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases	6
Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids	6
Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review	6
Streptococcal infection in childhood Henoch-Schönlein purpura: a 5-year retrospective study from a single tertiary medical center in China, 2015–2019	6
Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus	6
Blau syndrome: a case report from Palestine	5
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	5
Kawasaki disease with a concomitant primary Epstein - Barr virus infection	5
A novel transition clinic structure for adolescent and young adult patients with childhood onset rheumatic disease improves transition outcomes	5
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	5
Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis	5
Diffuse alveolar hemorrhage in children with trisomy 21	5
Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia	5
‘Snakes & Ladders’: factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis – a qualitative study	5

Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	5
Monitoring patients with juvenile idiopathic arthritis using health-related quality of life	5
Neuropsychological functioning and academic abilities in patients with juvenile idiopathic arthritis	5
Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants	5
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up	5
Suicidal risk and resilience in juvenile fibromyalgia syndrome: a cross-sectional cohort study	5
Mandibular range of motion in children with juvenile idiopathic arthritis with and without clinically established temporomandibular joint involvement and in healthy children; a cross-sectional study	5
Image guided sacroiliac joint corticosteroid injections in children: an 18-year single-center retrospective study	5
Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry	5
Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational d	5
Glucose metabolism in systemic juvenile idiopathic arthritis	5
Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus	5
Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study	5
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	5
Multisystem inflammatory syndrome in a fully vaccinated 18-year-old without known SARS-CoV-2 infection	5
Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis	5
Systemic lupus of pediatric onset in Afro-Caribbean children: a cohort study in the French West Indies and French Guiana	5
Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions	5
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept	5
Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature	5
Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA	5
Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis	5
Revising the WHO Essential Medicines List for paediatric rheumatology	5
Response to influenza vaccination in immunocompromised children with rheumatic disease: a prospective cohort study	5
Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	5
Development and validation of the Sorting non-trauMatIc adoLescent knEe pain (SMILE) tool – a development and initial validation study	5
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis	5
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	4
The association of MEFV gene mutations with the disease risk and severity of systemic juvenile idiopathic arthritis	4
The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertia	4
The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases	4
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients	4
Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease	4
Retropharyngeal abscess-like as an atypical presentation of Kawasaki disease: a case report and literature review	4
Development and validation of the RACER (Readiness for Adult Care in Rheumatology) transition instrument in youth with juvenile idiopathic arthritis	4
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	4
Abstracts from the ISSAID 2021 Periodic Congress	4
Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective	4
Biomarkers of lipid metabolism in patients with juvenile idiopathic arthritis: relationship with disease subtype and inflammatory activity	4
Monocyte platelet aggregates in children with Kawasaki disease- a preliminary study from a tertiary care centre in North-West India	4
Intravoxel incoherent motion (IVIM) MRI in pediatric patients with synovitis of the knee joint: a prospective pilot study	4
Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series	4
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	4
Identifying the content and context of pain within paediatric rheumatology healthcare professional curricula in the UK: a summative content analysis	4
A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis	4
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	4
Joint injection practice variations in pediatric rheumatology – a global survey and call for action	4
The culture microenvironment of juvenile idiopathic arthritis synovial fibroblasts is favorable for endochondral bone formation through BMP4 and repressed by chondrocytes	4
Experiences, perspectives and expectations of adolescents with juvenile idiopathic arthritis regarding future work participation; a qualitative study	4
Childhood-onset primary Sjögren’s syndrome in a tertiary center in China: clinical features and outcome	4
Homozygous variant p. Arg90His in NCF1 is associated with early-onset Interferonopathy: a case report	4
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	4
Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature	4
Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus	4
Assessing preparation for care transition among adolescents with rheumatologic disease: a single-center assessment with patient survey	4
Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience	4
A familial case of Kikuchi-Fujimoto disease in dizygotic twins	4
Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)	4
A case of Myhre syndrome mimicking juvenile scleroderma	4
Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study	4
Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature	4
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis	4
Economic impact of Juvenile Idiopathic Arthritis: a systematic review	4
Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report	4
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis	4
Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden	4
Effect of different doses of aspirin on the prognosis of Kawasaki disease	4
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study	4
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study	4
Is podocytopathy another image of renal affection in p-SLE?	3
Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature	3
A case of rectal ulcers during aspirin therapy in acute Kawasaki disease	3
Genetics of chronic nonbacterial osteomyelitis in the irish population: no significant association with rare FBLIM1 variants	3
Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry	3
Necrotizing Funisitis as an Intrauterine manifestation of Cryopyrin-Associated Periodic Syndrome: a case report and review of the literature	3
Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study	3
Explaining juvenile idiopathic arthritis to paediatric patients using illustrations and easy-to-read texts: improvement of disease knowledge and adherence to treatment	3
Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population	3
Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registry	3
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis	3
A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis	3
Juvenile idiopathic arthritis in Jordan: single center experience	3
Reducing fatigue in pediatric rheumatic conditions: a systematic review	3
A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report	3
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency	3
Proceedings of the 26th European Paediatric Rheumatology Congress: part 1	3
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study	3
Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE	3
Joint involvement, disease activity and quality of life in pediatric Crohn’s disease – a cross-sectional study	3
Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies	3
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	3
Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry	3
Revising the WHO Essential Medicines List for paediatric rheumatology update	3
Recurrent Henoch-Schönlein Purpura with bullous rash and pulmonary nodules	3
Coexistence of a novel WISP3 pathogenic variant and an MEFV mutation in an Arabic family with progressive pseudorheumatoid dysplasia mimicking polyarticular juvenile idiopathic arthritis	3